Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 19.45% Profit Gain

February 01, 2024
ELI LILLY AND COMPANY stock recently achieved the price target forecast set by QuantWave, resulting in a profitable gain of 19.45%. The forecast signal was issued on October 31, 2023, with a predicted long direction at a price of 546.06 $. The target price of 652.25 $ was reached on February 1, 2024.

This successful forecast for ELI LILLY AND COMPANY reflects the accuracy and reliability of QuantWave's analytics. Market analysis suggests that factors such as strong financial performance, positive industry trends, and strategic partnerships have contributed to the bullish movement of the stock. Investors who followed QuantWave's forecast would have capitalized on this upward trend and reaped significant profits.

QuantWave, as an automated forecasting platform, offers users access to predictions for various stocks, providing a valuable opportunity for potential profits. For those interested in delving deeper into investment strategies, QuantSchool offers professional educational resources outlining the key principles for generating consistent income using QuantWave's forecasting system.

Overall, the achievement of the price target forecast for ELI LILLY AND COMPANY demonstrates the effectiveness of QuantWave's analytics in guiding investors towards profitable opportunities in the stock market.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 8, 2025ELI LILLY AND COMPANY Hits Price Target Forecast with 18.31% Profit - QuantWave Achieves Success Once Again  ~2 min.

ELI LILLY AND COMPANY, one of the leading pharmaceutical companies, recently saw its stock price hitting the forecasted target with a profit of 18.31% as predicted by QuantWave on June 4, 2025....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast as QuantWave Users Gain 17.38% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved the price target forecast set by QuantWave, marking a significant success for users of the automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Target Forecast with 17.25% Profit: A Success Story for QuantWave  ~2 min.

ELI LILLY AND COMPANY, a leading pharmaceutical company, recently saw its stock hit the target forecast set by QuantWave, yielding a profit of 17.25%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Profit of 23.55%: A Success Story for QuantWave  ~2 min.

ELI LILLY AND COMPANY, a prominent player in the pharmaceutical industry, recently achieved a significant milestone by hitting a price target forecast generated by the innovative forecasting platform, QuantWave. The forecast, which indicated a short direction signal on April 17, 2025, at a price of 836.4 USD, proved to be accurate as the stock reached the predicted target price of 639.46 USD on Au...


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Target Forecast with 22.13% Profit  ~1 min.

ELI LILLY AND COMPANY stock successfully reached the forecasted target price of 639.46 $ on August 7, 2025, resulting in a profit of 22.13% for investors....


LLYAugust 1, 2025Eli Lilly and Company Completes Acquisition of Verve Therapeutics, Advancing One-Time Treatments for High Cardiovascular Risk  ~1 min.

Eli Lilly and Company has announced the successful completion of its acquisition of Verve Therapeutics, a move that will help advance innovative one-time treatments for individuals with high cardiovascular risk. This strategic decision showcases the company's commitment to revolutionizing the healthcare industry and improving patient outcomes. Investors are eagerly watching as Eli Lilly continues ...


LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....


AMZNNovember 14, 2024Amazon.com Inc. AMZN: Expanding AI Reach with Defense Partnerships  ~1 min.

Amazon.com Inc. (AMZN) continues to solidify its position in the artificial intelligence (AI) sector by forging strategic partnerships with defense organizations....


FORDDecember 19, 2024Ford Forward Industries, Inc. Expands Partnership and Secures Investment for NeuStim Launch  ~2 min.

Forward Industries' subsidiary, Neuvotion, has recently announced an expansion in their AI-driven neurotech partnership and has secured significant investment for the launch of their latest product, NeuStim. The partnership aims to revolutionize the field of neurotechnology and provide innovative solutions for patients suffering from various neurological conditions. NeuStim is a groundbreaking dev...


STLAFebruary 12, 2025Stellantis and Mistral AI Strengthen Strategic Partnership  ~2 min.

Stellantis N.V., the multinational automotive company, and Mistral AI, a leading artificial intelligence solutions provider, have announced the strengthening of their strategic partnership....


ELMarch 20, 2025The Este Lauder Companies Announces Strategic Partnership with India's Ministry of Commerce and Industry  ~2 min.

The Este Lauder Companies Inc., a renowned global beauty company, has recently entered into a strategic partnership with India's Ministry of Commerce and Industry....


VET-USDJanuary 7, 2025VeChain VET Coin: Future Potential and Price Predictions for 2025  ~2 min.

VeChain (VET) is a blockchain platform that aims to revolutionize supply chain management and ensure product authenticity....